LTBP2 inhibits prostate cancer progression and metastasis via the PI3K/AKT signaling pathway

Biochemical recurrence (BCR) is a cause of concern in advanced prostate cancer (PCa). Thus, novel diagnostic biomarkers are required to improve clinical care. However, research on PCa immunotherapy is also scarce. Hence, the present study aimed to explore promising BCR-related diagnostic biomarkers,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaowen, Tian, Chuanjie, Cheng, Jianbin, Mao, Weipu, Li, Menglan, Chen, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400130/
https://www.ncbi.nlm.nih.gov/pubmed/36034756
http://dx.doi.org/10.3892/etm.2022.11500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400130/
https://www.ncbi.nlm.nih.gov/pubmed/36034756
http://dx.doi.org/10.3892/etm.2022.11500

Ejemplares similares